Heloisa H. Ruocco

Francisco Telles Street
Jundiai, SP 13202550, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous system.

Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous system.

Journal: Arquivos de neuro-psiquiatria

Published: April 24, 2021

Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorders.

Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorders.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: September 02, 2020

Severe Exacerbation of Multiple Sclerosis Following Withdrawal of Fingolimod.

Severe Exacerbation of Multiple Sclerosis Following Withdrawal of Fingolimod.

Journal: Clinical drug investigation

Published: June 02, 2019

Late Onset of Neuromyelitis Optica Spectrum Disorders.

Late Onset of Neuromyelitis Optica Spectrum Disorders.

Journal: Neurology and therapy

Published: April 25, 2019

Migraine in 746 patients with multiple sclerosis.

Migraine in 746 patients with multiple sclerosis.

Journal: Arquivos de neuro-psiquiatria

Published: March 17, 2019

High levels of alexithymia in patients with multiple sclerosis.

High levels of alexithymia in patients with multiple sclerosis.

Journal: Dementia & neuropsychologia

Published: July 11, 2018

Seroconversion of JCV antibodies is strongly associated to natalizumab therapy.

Seroconversion of JCV antibodies is strongly associated to natalizumab therapy.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: June 21, 2018

No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° South.

No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° South.

Journal: Arquivos de neuro-psiquiatria

Published: August 07, 2016

Interferon-γ Is Associated with Cerebral Atrophy in Systemic Lupus Erythematosus.

Interferon-γ Is Associated with Cerebral Atrophy in Systemic Lupus Erythematosus.

Journal: Neuroimmunomodulation

Published: August 02, 2016

Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders.

Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders.

Journal: NeuroRehabilitation

Published: July 04, 2016

Guillain-Barré syndrome and dengue fever: report on ten new cases in Brazil.

Guillain-Barré syndrome and dengue fever: report on ten new cases in Brazil.

Journal: Arquivos de neuro-psiquiatria

Published: June 17, 2016

Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis.

Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis.

Journal: Expert review of clinical pharmacology

Published: January 23, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026